Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Tuesday, September 15, 2015

Special Report: Oral Treatments for MS

In the past few years, research has lead to the approval of new oral treatment options for the treatment of relapsing form of multiple sclerosis, or RRMS.
While infusions, interferon and other injectables are still used by a majority of MS patients, the recent MS in America 2014 survey completed by over 5,000 respondents showed that oral medications for MS are used by almost a third of patients, and over 50% of people using injectables are considering switching to an oral.
In this special report we take a closer look at the use of oral medications for MS including the reason people switched, patient-reported satisfaction, the type of dialogue they had with their doctor, and much more information that anyone considering an oral therapy for MS might find useful.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide 
by signing up by clicking here
.===================================

No comments: